V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008202 | 280005404 | 1.77 | null | Curative (C) | 2017-02-22 | 2017-03-01 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026673 | RMS 2005 TRIAL |
| 280008203 | 280005404 | 1.7 | 89 | Palliative (P) | 2014-08-19 | 2014-08-19 | Cetuximab + Radiotherapy Load | N | N | 280026673 | CETUXIMAB + RT |
| 280008204 | 280008848 | 1.57 | 48 | Curative (C) | null | 2015-10-01 | Cetuximab + Radiotherapy Maint | N | Y | 280026689 | CETUXIMAB + RT |
| 280008205 | 280008849 | 1.73 | 59 | Neo-adjuvant (N) | 2014-08-01 | 2014-10-09 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | 280026692 | RMS 2005 TRIAL |
| 280008206 | 280008849 | 1.66 | 88 | Curative (C) | 2013-05-15 | 2013-06-04 | Cetuximab + Radiotherapy Maint | Y | Y | 280026692 | CETUXIMAB + RT |
| 280008207 | 280008849 | 1.72 | 74.5 | Neo-adjuvant (N) | null | 2014-04-07 | Cetuximab + Radiotherapy Maint | 02 | N | 280026692 | CETUXIMAB + RT |
| 280008208 | 280005407 | 1.63 | 88 | Neo-adjuvant (N) | 2015-05-14 | 2015-07-23 | Paclitaxel 7 day | 02 | N | 280026700 | PACLITAXEL |
| 280008209 | 280005410 | 1.53 | null | Palliative (P) | 2014-04-17 | 2014-04-17 | PACLITAXEL | N | N | 280026704 | PACLITAXEL |
| 280008210 | 280008853 | 1.74 | 85.2 | Neo-adjuvant (N) | 2016-11-14 | 2016-11-14 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280026704 | PACLITAXEL |
| 280008211 | 280008853 | 1.75 | null | Curative (C) | 2015-03-21 | 2015-03-26 | Cetuximab + Radiotherapy Maint | null | null | 280026704 | CETUXIMAB + RT |
| 280008212 | 280008853 | 1.88 | 91.9 | Neo-adjuvant (N) | null | 2017-02-28 | Ifosfamide | 2 | N | 280026704 | IFOSFAMIDE |
| 280008213 | 280005416 | 1.74 | 141.6 | Palliative (P) | 2017-07-03 | 2017-07-08 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | 280026722 | PACLITAXEL |
| 280008214 | 280008854 | 1.56 | 65 | null | 2015-03-16 | 2015-03-28 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026724 | PACLITAXEL |
| 280008215 | 280008855 | 1.55 | 52.4 | Palliative (P) | 2013-07-26 | 2013-07-28 | DOXORUBICIN | N | N | 280026726 | DOXORUBICIN |
| 280008216 | 280005423 | 1.88 | 115.65 | null | 2014-10-05 | 2014-11-05 | CARBOPLATIN + RT | N | Y | 280026731 | CARBOPLATIN + RT |
| 280008217 | 280005424 | 1.8 | null | Palliative (P) | 2015-11-24 | 2015-11-24 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 280026741 | PACLITAXEL |
| 280008218 | 280005425 | 1.75 | 85.2 | Palliative (P) | 2013-03-30 | 2013-08-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026741 | PACLITAXEL |
| 280008219 | 280005427 | 1.66 | null | Palliative (P) | 2016-12-06 | 2017-05-08 | Ifosfamide | N | N | 280026746 | IFOSFAMIDE |
| 280008220 | 280008857 | 1.63 | 51.2 | Neo-adjuvant (N) | 2014-04-28 | 2014-07-05 | Cisplatin | 02 | Y | 280026746 | CISPLATIN |
| 280008221 | 280008857 | 1.6 | 58 | Curative (C) | 2016-09-05 | 2016-10-01 | Cisplatin 7 day | 02 | N | 280026746 | CISPLATIN |
| 280008222 | 280011911 | 1.72 | 122 | Adjuvant (A) | 2018-03-27 | 2018-05-26 | CARBOPLATIN + RT | N | Y | 280026756 | CARBOPLATIN + RT |
| 280008223 | 280005428 | 1.63 | 65.3 | Palliative (P) | 2017-12-08 | 2018-01-03 | Cetuximab + Radiotherapy Maint | N | Y | 280026758 | CETUXIMAB + RT |
| 280008224 | 280005428 | null | 48.5 | Palliative (P) | 2014-10-30 | 2014-11-14 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280026758 | RMS 2005 TRIAL |
| 280008225 | 280005429 | 1.58 | 110.8 | Palliative (P) | 2017-11-10 | 2017-12-18 | Cisplatin | N | N | 280026780 | CISPLATIN |
| 280008226 | 280005429 | 1.6 | 70.1 | Adjuvant (A) | 2013-09-25 | 2013-10-09 | CETUXIMAB + RT | N | Y | 280026780 | CETUXIMAB + RT |
| 280008227 | 280005430 | null | 86.1 | Adjuvant (A) | 2015-11-13 | 2015-11-17 | CARBOPLATIN + RT | 02 | Y | 280026783 | CARBOPLATIN + RT |
| 280008228 | 280005431 | 0 | 92 | Palliative (P) | null | 2017-09-15 | STS Rhabdo RMS 2005 Vin Cyclo | 01 | N | 280026787 | RMS 2005 TRIAL |
| 280008229 | 280005432 | 1.57 | 54.35 | Palliative (P) | 2013-07-13 | 2014-09-22 | Ifosfamide PVI 1g/m2 14day | N | N | 280026793 | IFOSFAMIDE |
| 280008230 | 280008860 | 0 | 48.1 | Palliative (P) | 2015-10-30 | 2015-11-04 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | null | 280026794 | IVA |
| 280008231 | 280008860 | 1.87 | 66.1 | Palliative (P) | 2015-08-06 | 2015-08-07 | Ifosfamide | N | N | 280026794 | IFOSFAMIDE |
| 280008232 | 280008860 | 1.79 | 88 | Palliative (P) | 2018-02-22 | 2018-02-24 | Ifosfamide PVI 1g/m2 14day | 2 | N | 280026794 | IFOSFAMIDE |
| 280008233 | 280005436 | 1.75 | 81.45 | Palliative (P) | 2014-09-16 | 2014-09-19 | Cisplatin | Y | N | 280026803 | CISPLATIN |
| 280008234 | 280005441 | 1.75 | 64 | Palliative (P) | null | 2015-12-31 | Doxorubicin 75mg/m2 | null | null | 280026803 | DOXORUBICIN |
| 280008235 | 280010512 | 1.82 | 85 | Adjuvant (A) | null | 2017-11-19 | CETUXIMAB + RT | 02 | N | 280026807 | CETUXIMAB + RT |
| 280008236 | 280010512 | 1.92 | 74 | Palliative (P) | 2015-12-04 | 2015-12-25 | DOXORUBICIN | N | N | 280026807 | DOXORUBICIN |
| 280008237 | 280010512 | 1.78 | 35.5 | Palliative (P) | 2014-10-31 | 2014-11-28 | CETUXIMAB + RT | N | Y | 280026807 | CETUXIMAB + RT |
| 280008238 | 280005443 | 1.74 | 115.65 | Palliative (P) | 2018-10-08 | 2018-10-16 | DOXORUBICIN | 02 | null | 280026812 | DOXORUBICIN |
| 280008239 | 280005444 | 1.78 | 123 | Palliative (P) | 2015-08-09 | 2015-08-24 | Cetuximab + Radiotherapy Maint | null | null | 280026812 | CETUXIMAB + RT |
| 280008240 | 280010513 | 1.86 | 86.8 | Palliative (P) | 2016-03-16 | 2016-03-16 | PACLITAXEL | N | N | 280026817 | PACLITAXEL |
| 280008241 | 280005446 | 1.7 | 48.1 | Palliative (P) | 2013-07-09 | 2015-12-28 | DOXORUBICIN | N | N | 280026819 | DOXORUBICIN |
| 280008242 | 280005448 | 0 | 78 | Palliative (P) | 2016-09-04 | 2016-12-09 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026821 | IVA |
| 280008243 | 280008867 | null | 67.7 | Palliative (P) | 2017-12-08 | 2018-01-05 | Cisplatin | N | null | 280026823 | CISPLATIN |
| 280008244 | 280008867 | null | null | Palliative (P) | null | 2014-03-20 | DOXORUBICIN | N | N | 280026823 | DOXORUBICIN |
| 280008245 | 280005450 | 1.54 | 84.8 | Palliative (P) | 2013-07-27 | 2013-07-27 | Paclitaxel 7 day | 02 | N | 280026824 | PACLITAXEL |
| 280008246 | 280005450 | 1.62 | 116 | Curative (C) | 2013-09-14 | 2013-10-02 | Cisplatin | N | Y | 280026824 | CISPLATIN |
| 280008247 | 280005451 | 1.74 | 72.6 | Adjuvant (A) | 2013-05-24 | 2013-05-28 | DOXORUBICIN | 1 | N | 280026839 | DOXORUBICIN |
| 280008248 | 280005453 | 1.69 | 72.7 | Curative (C) | 2013-09-30 | 2013-11-24 | Cetuximab + Radiotherapy Maint | 02 | N | 280026845 | CETUXIMAB + RT |
| 280008249 | 280008871 | 0 | 100.3 | Disease modification (D) | 2013-01-22 | 2014-02-16 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280026849 | RMS 2005 TRIAL |
| 280008250 | 280010516 | null | 38.1 | Curative (C) | 2016-04-23 | 2016-07-21 | STS Rhabdomyosarcoma RMS 2005 IVA | 1 | N | 280026850 | IVA |
| 280008251 | 280011712 | 1.81 | 111 | null | 2015-10-20 | 2015-11-21 | Paclitaxel 7 day | N | N | 280026861 | PACLITAXEL |